Outlook Therapeutics
(NASDAQ) OTLK
Outlook Therapeutics Financials at a Glance
Market Cap
$269.05M
Revenue (TTM)
$333.14K
Net Income (TTM)
-$60.96M
EPS (TTM)
-$1.09
P/E Ratio
-1.54
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$1.68
Volume
21,899
Open
$1.74
Price
$1.68
Volume
21,899
Open
$1.74
Previous Close
$1.68
Daily Range
$1.60 - $1.77
52-Week Range
$0.16 - $3.39
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$1.68
Volume
21,899
Open
$1.74
Previous Close
$1.68
Daily Range
$1.60 - $1.77
52-Week Range
$0.16 - $3.39
Estimated Earnings Date
Aug 13, 2026
OTLK News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Outlook Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
23
CEO
Robert Charles Jahr, MBA
Website
www.outlooktherapeutics.comHeadquarters
Iselin, NJ 08852, US
OTLK Financials
Key Financial Metrics (TTM)
Gross Margin
-360.85%
Operating Margin
-18182.76%
Net Income Margin
-18297.50%
Return on Equity
178.08%
Return on Capital
N/A
Return on Assets
-278.44%
Earnings Yield
-64.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$269.05M
Shares Outstanding
160.15M
Volume
21.90K
Avg. Volume
18.28M
Financials (TTM)
Gross Profit
-$1.20M
Operating Income
-$60.57M
EBITDA
-$62.08M
Operating Cash Flow
-$47.05M
Capital Expenditure
$0.00
Free Cash Flow
-$47.05M
Cash & ST Invst.
$7.75M
Total Debt
$27.19M
Outlook Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$127.44K
N/A
Gross Profit
-$21.89K
N/A
Gross Margin
-17.18%
N/A
Market Cap
$269.05M
N/A
Market Cap/Employee
$11.70M
N/A
Employees
23
N/A
Net Income
-$4.45M
+90.4%
EBITDA
-$14.00M
-13.2%
Quarterly Fundamentals
Total Cash
$7.75M
+2.5%
Total Debt
$27.19M
-18.4%
Accounts Receivable
$2.72M
N/A
Inventory
$3.34T
+92778738.6%
Long Term Debt
$11.28M
-46.9%
Short Term Debt
$15.91M
+32.0%
Return on Assets
-2.78%
N/A
Return on Invested Capital
3.56%
N/A
Free Cash Flow
-$7.83M
+52.8%
Operating Cash Flow
-$7.83M
+52.8%